NICE Says Initial No To Epidyolex In England, But GW Pharma Remains Upbeat

 
• By Ian Schofield
  
Rejected
NICE has rejected Epidyolex but GW Pharma still hopes for a positive outcome
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe